Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dragon III: FLOT vs SOX in gastric cancer
NCT03636893Phase 2Completed
- Sponsor
- Ruijin Hospital
- Start
- Aug 2018
- Primary completion
- Mar 2020
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, fluorouracil, folinic acid, oxaliplatin in gastric cancer (GC), sponsored by Ruijin Hospital. Started Aug 2018; status: completed.
02
Drugs
docetaxelfluorouracilfolinic acidoxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03636893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03636893.